Prudential Financial’s iShares Biotechnology ETF IBB Stock Holding History

Prudential Financial’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,780	Closed	-$359K	–	2651
2023 Q1	$359K	Hold	2,780	–	–	﹤0.01%	2213
2022 Q4	$365K	Hold	2,780	–	–	﹤0.01%	2159
2022 Q3	$325K	Sell	2,780 -266	-9%	-$33K	﹤0.01%	2268
2022 Q2	$358K	Buy	3,046 +459	+18%	+$54.5K	﹤0.01%	2270
2022 Q1	$337K	Sell	2,587 -1,807	-41%	-$235K	﹤0.01%	2357
2021 Q4	$711K	Buy	4,394 +979	+29%	+$152K	﹤0.01%	2043
2021 Q3	$593K	Buy	3,415 +385	+13%	+$64.8K	﹤0.01%	2077
2021 Q2	$496K	Sell	3,030 -3,102	-51%	-$478K	﹤0.01%	2144
2021 Q1	$923K	Sell	6,132 -5,889	-49%	-$935K	﹤0.01%	1869
2020 Q4	$1.82M	Sell	12,021 -1,121	-9%	-$160K	﹤0.01%	1458
2020 Q3	$1.78M	Buy	13,142 +1,345	+11%	+$182K	﹤0.01%	1370
2020 Q2	$1.61M	Buy	+11,797	New	+$1.5M	﹤0.01%	1437

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Prudential Financial's IBB Position: Q2 2023 in Review

Prudential Financial sold out of iShares Biotechnology ETF (IBB) in Q2 2023, closing a stake of 2,780 shares — an estimated $359K sold.

Prudential Financial first reported a position in IBB in Q2 2020 and held it in 12 quarters. The position peaked at $1.82M in Q4 2020. 843 funds tracked by Wall St. Rank hold IBB as of Q2 2023.

Prudential Financial reported no remaining iShares Biotechnology ETF position as of Q2 2023 after selling out during the quarter.
Prudential Financial sold 2,780 iShares Biotechnology ETF shares in Q2 2023, an estimated $359K.
Prudential Financial first reported a position in iShares Biotechnology ETF in Q2 2020 and held it in 12 quarters.
Prudential Financial's iShares Biotechnology ETF position peaked at $1.82M in Q4 2020.
843 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2023.

Based on Prudential Financial's 13F filing for Q2 2023, filed 11 Aug 2023.